SABIC Innovative Plastics IP B.V.Download PDFPatent Trials and Appeals BoardAug 14, 202014015044 - (D) (P.T.A.B. Aug. 14, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/015,044 08/30/2013 Edward Norman Peters 12PLAS0401-US-NP 7551 43249 7590 08/14/2020 CANTOR COLBURN LLP - SABIC (NORYL) 20 Church Street 22nd Floor Hartford, CT 06103 EXAMINER LAN, YAN ART UNIT PAPER NUMBER 1782 NOTIFICATION DATE DELIVERY MODE 08/14/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): usptopatentmail@cantorcolburn.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte EDWARD NORMAN PETERS Appeal 2019-002748 Application 14/015,044 Technology Center 1700 ____________ Before JEFFREY B. ROBERTSON, GEORGE C. BEST, and BRIAN D. RANGE, Administrative Patent Judges. BEST, Administrative Patent Judge. DECISION ON APPEAL Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1–8, 10, 11, and 13–16 of Application 14/015,044. Final Act. (February 21, 2018). We have jurisdiction under 35 U.S.C. § 6. For the reasons set forth below, we affirm. 1 We use the word “Appellant” to refer to “Applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies SABIC Global Technologies B.V. as the real party in interest. Appeal Br. 2 Appeal 2019-002748 Application 14/015,044 2 I. BACKGROUND The ’044 Application describes thermoplastic polyurethanes exhibiting improved performance in one or more of tensile strength, heat resistance, hardness, and char formation. Spec. ¶ 3. These properties can be improved by incorporating 5 to 50 weight percent of a particulate engineering plastic having specific properties into the polyurethane thermoplastic resin. Id. ¶ 4. Claim 1 is representative of the ’044 Application’s claims and is reproduced below from the Claims Appendix of the Appeal Brief. 1. A composition comprising: 50 to 95 weight percent of a thermoplastic polyurethane, wherein the thermoplastic polyurethane is the reaction product of reactants comprising a polymeric diol and a diisocyanate; and 5 to 50 weight percent of a particulate engineering plastic; wherein the particulate engineering plastic comprises a polyarylethersulfone, a polyimide, a poly(phenylene sulfide), a semi-crystalline polyamide, or a combination thereof; wherein the particulate engineering plastic has a glass transition temperature or a crystalline melting point greater than or equal to 200 °C; wherein the particulate engineering plastic has a mean particle size of 5 to 600 micrometers; and wherein the weight percent values are based on the total weight of the composition. Appeal Br. 13. Appeal 2019-002748 Application 14/015,044 3 II. REJECTION On appeal, the Examiner maintains the following rejection: Claims 1– 8, 10, 11, and 13–16 are rejected under 35 U.S.C. § 103 as unpatentable over Thompson-Colon.2 Final Act. 6. III. DISCUSSION Appellant presents two arguments for reversal of all pending claims: (1) the lack of a motivation to select the specific particulate material from the list of materials described by Thompson-Colon, Appeal Br. 4–9, and (2) the lack of a reasonable expectation of success, see id. at 9–12. Because Appellant did not differentiate among the claims in making these arguments, we select claim 1 as representative of the claims on appeal for the purposes of these two arguments. 37 C.F.R. § 41.37(c)(1)(iv) (2018). Appellant also presents additional arguments3 for reversal of the rejection of claims 2 and 16. Appeal Br. 9. We address these arguments separately below. A. Rejection of claims 1–8, 10, 11, and 13–16 as unpatentable over Thompson-Colon In rejecting claim 1, the Examiner found that Thompson-Colon describes a composition comprising a thermoplastic polyurethane and particulate engineering plastic materials. Final Act. 6–7 (citing Thompson- Colon ¶¶ 21, 24–26, 53). The Examiner found that Thompson-Colon’s 2 US 2007/0093602 A1, published April 26, 2007. 3 We note that Appellant’s Appeal Brief does not comply with our rules regarding claims separately argued. See 37 C.F.R. § 41.37(c)(1)(iv) (2018) (“Under each heading identifying the ground of rejection being contested, any claim(s) argued separately or as a subgroup shall be argued under a separate subheading that identifies the claim(s) by number.”). In the future, Appellant’s counsel would do well to comply with the board’s rules. Appeal 2019-002748 Application 14/015,044 4 engineering plastic materials comprise polyethersulfone, polyimide, polyimide, poly (phenylene sulfide), and mixtures thereof which are the same materials as recited in claim 1. Id. at 7. The Examiner also found that Thompson-Colon’s engineering plastic materials would have the claimed properties because Thompson-Colon in claim 1 recite identical or substantially identical chemical compounds. Id. The Examiner found that Thompson-Colon describes its particles as having a mean particle size of less than 1000 µm, and preferably from 10 to 200 µm which overlaps the claimed size range. Id. (citing Thompson-Colon ¶ 50). The Examiner found that Thompson-Colon does not specifically teach the relative amounts of polyurethane and particulate engineering plastic material in its composition. Id. at 8. The Examiner, however, found that Thompson-Colon teaches the amount of the particulate plastic material is less than 50% by weight of the polyurethane (para [0051]). Thompson-Colon teaches that the particulate plastic material may be present in the compositions in an amount ranging between any combination of these argues inclusive of the recited values (para [0051]). Id. Based on these findings of fact, the Examiner concluded that, absent a showing of criticality with respect to the relative amounts of polyurethane and engineering plastic particles and the size of the particles, the subject matter of claim 1 would have been obvious to a person of ordinary skill in the art at the time of the invention. Id. at 8–9. As discussed above, Appellant presents two arguments for the reversal of the rejection of claim 1. We address these arguments separately below. Appeal 2019-002748 Application 14/015,044 5 1. Appellant’s argument regarding motivation to select claimed polyarylethersulfone, polyimide, and poly(phenylene sulfide), semi-crystalline polyamide, or a combination of thereof as the organic particulate material Appellant argues that claim 1 is patentable over Thompson-Colon because Appellant argues that Thompson-Colon provides no reason to select any of the claimed particulate engineering plastics from among the dozens of organic particulate materials it describes. Appeal Br. 5. Appellant maintains that the person having ordinary skill in the art would have to do much picking and choosing from Thompson-Colon’s vast lists of materials to arrive at the claimed invention. Id. Appellant asserts that the rejection should be reversed because Thompson-Colon gives no indication or direction that would lead a person of skill in the art to select the claimed materials. Id. at 5–9 (citing In re Kubin, 561 F.3d 1351, 1359 (Fed. Cir. 2009)). We are not persuaded by this argument. As the Federal Circuit has held, the fact that a reference “discloses a multitude of effective combinations does not render any particular formulation less obvious.” Merck & Co. v. Biocraft Labs., Inc., 874 F.2d 804, 807 (Fed. Cir. 1989); see also In re Susi, 440 F.2d 442, 445 (CCPA 1971) (obviousness rejection affirmed where the disclosure of the prior art was “huge, but it undeniably include[d] at least some of the compounds recited in appellant’s generic claims and [was] of a class of chemicals to be used for the same purpose as appellant’s additives”). Appellant’s claims are directed to a selection from the broadly disclosed organic particulate materials in Thompson-Colon. Appellant’s claims may be patentable if they are directed to compositions that provide unexpected results relative to the closest prior art. Appellant does not point Appeal 2019-002748 Application 14/015,044 6 us to any evidence supporting such a finding. We, therefore, cannot reverse the rejection of claim 1 on this basis. 2. Appellant’s argument regarding the expectation of success for 5–600 µm polyarylethersulfone, polyimide, poly(phenylene sulfide), or semi-crystalline polyamide particles Appellant argues that claim 1 is patentable over Thompson-Colon because “[the] reference provides no expectation of success for the use of a polyarylethersulfone, polyimide, poly(phenylene sulfide), semi-crystalline polyamide, or a combination thereof having a mean particle size range of 5 to 600 µm.” Appeal Br. 9. In particular, Appellant argues that its inventor determined that improvements in one or more of tensile strength, heat resistance, hardness, and char formation are imparted to thermoplastic polyurethanes by incorporating particulate engineering thermoplastics with a mean particle size between 5 and 600 µm. Id. at 10 (citing Spec. ¶¶ 10, 78– 81). Appellant asserts that Thompson-Colon was not concerned with providing compositions having improved tensile strength, heat resistance, hardness, and/or char formation. Id. at 11. Appellant argues that Thompson- Colon’s lack of disclosure regarding these properties means that a person of ordinary skill in the art would not have had a reasonable expectation of success in improving any of these properties. Id. We are not persuaded by Appellant’s argument. The reasonable expectation of success inquiry looks to “likelihood of success in combining references to meet the limitations of the claimed invention.” Intelligent Bio- Systems, Inc. v. Illumina Cambridge, Ltd., 821 F.3d 1359, 1367 (Fed. Cir. 2016). As the Examiner notes, claim 1 does not recite the properties Appellant argues. Ans. 12. The art suggests the recitations of claim 1, as we Appeal 2019-002748 Application 14/015,044 7 explain above, and thus indicates that the recitations of claim 1 could be successfully reached. Id. Appellant does not present persuasive argument or evidence to the contrary. PAR Pharm., Inc. v. TWI Pharms., Inc., 773 F.3d 1186, 1198 (Fed. Cir. 2014). (“The reasonable expectation of success requirement for obviousness does not necessitate an absolute certainty for success.”). Moreover, “[u]nexpected properties . . . do not necessarily guarantee that a new compound is nonobvious.” Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc., 752 F.3d 967, 977 (Fed. Cir. 2014). Rather, these unexpected properties are objective evidence of nonobviousness and must be sufficient to outweigh any evidence of obviousness that might exist when all the evidence for and against patentability is weighed together. See In re Oetiker, 977 F.2d 1443, 1445 (Fed. Cir. 1992) (“[P]atentability is determined on the totality of the record, by a preponderance of evidence with due consideration to persuasiveness of argument.”); In re Rinehart, 531 F.2d 1048, 1052 (CCPA 1976) (“When prima facie obviousness is established and evidence is submitted in rebuttal, the decision-maker must start over.”). In this case, Appellant has not provided us with any evidence comparing the properties of the claimed compositions to the closest prior art—i.e., the compositions exemplified in Thompson-Colon. Because Appellant has not provided evidence of any differences, let alone unexpected differences, we do not reverse the rejection of claim 1. B. Appellant’s additional arguments for reversal of the rejection of claims 2 and 16 Appellant presents additional arguments for reversal of the rejection of claims 2 and 16. Appeal Br. 9. In particular, claim 2 specifies that the Appeal 2019-002748 Application 14/015,044 8 particulate engineering plastic is a polyarylethersulfone, and claim 16 specifies a particular polyarylethersulfone. Id. Appellant argues that the Examiner erred by finding that Thompson-Colon describes or suggests the polyurethane compositions including these specific particulate engineering plastic additives. Id. We do not reverse the rejection of either claim 2 or claim 16. As discussed above, Thompson-Colon renders the compositions recited in either of these claims prima facie obvious. Appellant has not provided any evidence comparing the claimed compositions to the closest prior art, which is the compositions exemplified in Thompson-Colon. Thus, we affirm the rejection of claims 2 and 16 as obvious. IV. CONCLUSION In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1–8, 10, 11, 13–16 103 Thompson-Colon 1–8, 10, 11, 13–16 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED Copy with citationCopy as parenthetical citation